| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss from operations | -10,883 | -11,093 | -9,941 | -10,956 |
| Interest and other income, net | 1,687 | 895 | 1,123 | 1,343 |
| Total other income | 1,687 | 895 | 1,123 | 1,343 |
| Loss before income taxes | -9,196 | -10,198 | - | -9,613 |
| Income tax expense | 0 | 0 | - | - |
| Net loss | -9,196 | -10,198 | -8,818 | -9,613 |
| Unrealized gain (loss) on marketable debt securities | 189 | -26 | -42 | 137 |
| Comprehensive loss | -9,007 | -10,224 | -8,860 | -9,476 |
| Earnings per share, basic | -0.72 | -1.33 | -1.17 | -1.51 |
| Earnings per share, diluted | -0.72 | -1.33 | -1.17 | -1.51 |
| Weighted average number of shares outstanding, basic | 12,686,122 | 7,655,854 | 7,506,321 | 6,351,431 |
| Weighted average number of shares outstanding, diluted | 12,686,122 | 7,655,854 | 7,506,321 | 6,351,431 |
ASSEMBLY BIOSCIENCES, INC. (ASMB)
ASSEMBLY BIOSCIENCES, INC. (ASMB)